Metraipolis › archive › dc_ca59a2ecea97

A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC… — Europe PMC PMID:41827675

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41827675
DOI
10.3390/cancers18050740
License (as archived)
solo-consultazione
Archived
2026-11-05T12:16:11.923Z
SHA-256 of the archived text
727a5704a926218f65d9d0756709dc48eb943f63fd55ab550104b19dd938bd37
Stable URL of this page
https://metraipolis.com/documento/dc_ca59a2ecea97

How to cite

A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC… — Europe PMC PMID:41827675 — Europe PMC (en), https://europepmc.org/article/MED/41827675 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca59a2ecea97 (Metraipolis archive dc_ca59a2ecea97, sha256 727a5704a926218f65d9d0756709dc48eb943f63fd55ab550104b19dd938bd37)
BibTeX
@misc{dcca59a2ecea97,
  title = {A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC… — Europe PMC PMID:41827675},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41827675},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca59a2ecea97; sha256 727a5704a926218f65d9d0756709dc48eb943f63fd55ab550104b19dd938bd37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41827675. Agents can read the archived copy with the MCP tool read_document.